Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Alaupovic

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
Scandinavian Journal of Rheumatology|March 10, 2012
Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular diseaseN Knowlton, J A Wages, M B Centola, et al.
FEBS Letters|June 24, 1971
Differential activation of lipoprotein lipase from human post-heparin plasma, milk and adipose tissue by polypeptides of human serum Apolipoprotein CD Ganesan, R H. Bradford, P Alaupovic, et al.
Biochimica Et Biophysica Acta|July 26, 1984
Catabolism of human low density lipoproteins by human hepatoma cell line HepG2N Dashti, G Wolfbauer, E Koren, et al.
Biochemistry|May 8, 1973
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08L Tarcsay, C S Wang, S C Li, et al.
FEBS Letters|April 7, 1980
Isolation and partial characterization of apolipoprotein D and lipoprotein D from baboon plasmaD Bojanovski, P Alaupovic, W J McConathy, et al.
American Journal of Nephrology|January 1, 1984
Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failureP O Attman, A Gustafson, P Alaupovic, et al.
Metabolism: Clinical and Experimental|November 1, 1976
Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels?D Ganesan, H B Bass, W J McConathy, et al.
Contributions to Nephrology|January 1, 1988
Lipid metabolism in patients with chronic renal failure in the predialytic phaseP O Attman, A Gustafson, P Alaupovic, et al.
The Journal of Clinical Investigation|December 1, 1970
A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteinsD Seidel, P Alaupovic, R H Furman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failureP O Attman, P Alaupovic, M Tavella, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Scandinavian Journal of Rheumatology|March 10, 2012
Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular diseaseN Knowlton, J A Wages, M B Centola, et al.
FEBS Letters|June 24, 1971
Differential activation of lipoprotein lipase from human post-heparin plasma, milk and adipose tissue by polypeptides of human serum Apolipoprotein CD Ganesan, R H. Bradford, P Alaupovic, et al.
Biochimica Et Biophysica Acta|July 26, 1984
Catabolism of human low density lipoproteins by human hepatoma cell line HepG2N Dashti, G Wolfbauer, E Koren, et al.
Biochemistry|May 8, 1973
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08L Tarcsay, C S Wang, S C Li, et al.
FEBS Letters|April 7, 1980
Isolation and partial characterization of apolipoprotein D and lipoprotein D from baboon plasmaD Bojanovski, P Alaupovic, W J McConathy, et al.
American Journal of Nephrology|January 1, 1984
Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failureP O Attman, A Gustafson, P Alaupovic, et al.
Metabolism: Clinical and Experimental|November 1, 1976
Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels?D Ganesan, H B Bass, W J McConathy, et al.
Contributions to Nephrology|January 1, 1988
Lipid metabolism in patients with chronic renal failure in the predialytic phaseP O Attman, A Gustafson, P Alaupovic, et al.
The Journal of Clinical Investigation|December 1, 1970
A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteinsD Seidel, P Alaupovic, R H Furman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failureP O Attman, P Alaupovic, M Tavella, et al.
Pageof 19